Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
30.05B | 28.88B | 26.66B | 25.30B | 23.89B | Gross Profit |
30.05B | 28.88B | 26.66B | 25.30B | 23.89B | EBIT |
-83.17B | 6.50B | 10.75B | 3.25B | 874.00M | EBITDA |
0.00 | 7.66B | 7.38B | 5.30B | 2.96B | Net Income Common Stockholders |
3.37B | 4.27B | 5.53B | 2.37B | 495.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
187.89B | 213.43B | 217.77B | 222.74B | 231.17B | Total Assets |
1.39T | 1.31T | 1.34T | 1.32T | 1.32T | Total Debt |
151.49B | 144.22B | 146.38B | 156.19B | 152.72B | Net Debt |
-2.16B | -40.34B | -39.71B | -43.17B | -22.62B | Total Liabilities |
1.31T | 1.24T | 1.26T | 1.26T | 1.26T | Stockholders Equity |
77.83B | 73.05B | 70.54B | 66.33B | 60.60B |
Cash Flow | Free Cash Flow | |||
-29.11B | 5.18B | -2.45B | -3.50B | 30.22B | Operating Cash Flow |
-28.58B | 3.83B | -2.11B | -2.95B | 30.74B | Investing Cash Flow |
-6.78B | -2.58B | -17.18B | 23.59B | -1.89B | Financing Cash Flow |
-646.00M | -1.08B | 614.00M | 1.63B | -311.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | €29.11B | 11.70 | 8.06% | 1.44% | 17.06% | 25.66% | |
74 Outperform | €484.23M | 10.03 | 7.00% | 3.88% | 16.97% | -54.69% | |
73 Outperform | $45.75B | 10.32 | 6.68% | 1.81% | 3.36% | 3.08% | |
69 Neutral | €85.85B | 7.98 | 9.58% | 6.02% | 5.65% | 11.45% | |
64 Neutral | $12.51B | 9.81 | 7.92% | 16985.69% | 12.67% | -5.98% |